HR 10094·Federal·house
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
In CommitteeFiled Aug 13, 2026
Sponsor: Rep. Hoyle, Val T. [D-OR-4] (D)
Latest Action
Referred to the House Committee on Energy and Commerce.
Aug 13, 2026
Summary
HR 10094, the Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026, would address the pricing of prescription medications that are financed by federal programs. It targets patients who receive drugs through taxpayer‑funded programs and the taxpayers themselves, seeking to make those drugs more affordable. The measure is currently referred to the House Committee on Energy and Commerce.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 10094 changes status, plus AI-powered summaries and stage predictions.
Sign up free